Research ArticleResearch

Honey plus cryotherapy delayed and reduced radiation mouth sores in head and neck cancer patients

Oncology Research and Treatment (PubMed)Jun 22, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In a single-center prospective study of 72 head and neck cancer patients receiving concurrent chemoradiotherapy, adding honey and cryotherapy to routine care delayed the onset of radiation-induced oral mucositis and lowered the incidence of moderate-to-severe cases compared with routine nursing care alone.

What NurseJet pulled from the source

This single-center prospective comparative study enrolled 72 head and neck cancer patients receiving concurrent chemoradiotherapy at a specialized oncology institution between July 2021 and May 2022, allocating 36 to honey plus cryotherapy and 36 to routine nursing care. The intervention was applied before radiotherapy, 15 minutes after, and 6 hours afterward, with radiation-induced oral mucositis (RTOM) graded by Radiation Therapy Oncology Group (RTOG) criteria. The intervention group had a later onset of RTOM (15.58 ± 4.60 days vs 11.58 ± 6.22 days; P = 0.003) and a lower incidence of grade II or higher RTOM (11.11% vs 33.33%; P = 0.045). Severity grading also differed significantly in the second week (P = 0.005) and third week (P = 0.014) of treatment.

Why this matters for nurses

Radiation-induced oral mucositis is one of the most painful and treatment-limiting complications of head and neck chemoradiotherapy, and it can force breaks in therapy. This study may matter for nurses because it tests a simple, low-cost bedside intervention, honey plus ice, that patients can tolerate and that nursing staff can deliver.

Bedside takeaway

Be aware that in a small single-center study, adding honey and cryotherapy around radiotherapy delayed radiation mouth sores (about 15.6 vs 11.6 days to onset) and cut grade II or higher mucositis from 33% to 11%.

Explain this for my unit

Key takeaways

Honey combined with cryotherapy delayed the onset of radiation-induced oral mucositis (15.58 vs 11.58 days; P = 0.003).
The incidence of grade II or higher mucositis was lower with the intervention (11.11% vs 33.33%; P = 0.045).
Severity grading favored the intervention group in both the second week (P = 0.005) and third week (P = 0.014) of treatment.
The study was small (72 patients, 36 per group) and single-center, and the authors call for further validation.

Practice implications

For oncology nurses caring for head and neck cancer patients on chemoradiotherapy, the findings suggest that a structured honey and cryotherapy routine around radiotherapy sessions may postpone and soften oral mucositis, improving comfort and treatment tolerance. Any such protocol should be adopted through the treating team rather than improvised, given the small single-center evidence base.

Limitations & cautions

This was a single-center prospective study of only 72 patients conducted between July 2021 and May 2022, so the results may not generalize and could reflect local practice. The authors describe the benefit as probable and explicitly call for more comprehensive studies before honey plus cryotherapy is treated as established practice.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Oncology Research and Treatment (PubMed)

Oncology Research and Treatment (PubMed). Efficacy of Honey Combined with Cryotherapy in the Prevention and Management of Radiation-Induced Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Head and Neck Cancer.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42329022/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Clinical Journal of Oncology Nursing (PubMed)Sep 17, 2025Clinical Guideline

A new joint ONS/ASCO guideline standardizes how to manage chemotherapy extravasation, covering antidotes, thermal compresses, and when to refer for surgery.

OncologyAI summaryReview source

Clinical GuidelineGuidelineMedication SafetyAI summary · original source linked below

The Oncology Nursing Society and ASCO convened a panel that used GRADE methodology and a systematic review to build an evidence-based guideline on managing antineoplastic extravasation, the leak of a tissue-damaging drug into surrounding tissue. The recommendations cluster around three decisions: antidote use for vesicants and irritants with vesicant properties, thermal compress application and duration, and early surgical referral or specialty escalation, specifically for extravasation involving a central venous access device.

Key takeaways

ONS and ASCO jointly published a guideline on managing antineoplastic extravasation, built with GRADE methodology and a systematic review.
Recommendations address antidote use for vesicants and for irritants with vesicant properties.
They also address thermal compress application and how long to apply it.
They call for early surgical referral or specialty escalation for extravasation involving a central venous access device.

Why this matters on shift

Extravasation is rare, so the muscle memory for responding often isn't there when it happens at the chair. A current, jointly endorsed guideline may matter because it gives a defensible framework for the first minutes after a suspected leak, the period that most shapes tissue outcome, and it flags central-line extravasation as a scenario that may warrant early escalation rather than watchful waiting.

Bedside takeaway

Worth knowing that a new joint ONS/ASCO guideline standardizes chemotherapy extravasation response, covering antidote use, thermal compresses, and early escalation when a central line is involved.

Nursing implications

Know where your unit's extravasation protocol and antidote kit live before a leak happens, and confirm they reflect current ONS/ASCO guidance. Determine whether a leaked agent is a vesicant or an irritant with vesicant properties, apply the correct thermal compress for the recommended duration, and escalate a central venous access device extravasation early rather than waiting.

Limitations & cautions

As a consensus practice guideline, the strength of individual recommendations depends on evidence that is often limited for a rare event. The abstract names recommendation topics but not specific agents, temperatures, or durations, so the full text must be read before applying any intervention.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Clinical Journal of Oncology Nursing (PubMed). ONS/ASCO Guideline on the Management of Antineoplastic Extravasation.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

International Journal of Nursing Studies (PubMed)Dec 1, 2024Systematic Review

A network meta-analysis found that massage therapy ranked highest among non-pharmacological therapies for reducing cancer-related fatigue, though the certainty was low.

OncologyAI summaryReview source

Systematic ReviewResearchAI summary · original source linked below

Pooling 49 trials, 24 methods, and 3,887 patients, the analysis ranked massage therapy as having the most significant advantage over conventional nursing care and other non-drug therapies, followed by two moxibustion techniques; strengthening exercise ranked lowest. The authors stress that the small number of trials per therapy limits certainty.

Key takeaways

The network meta-analysis pooled 49 trials, 24 methods, and 3,887 patients.
Massage therapy ranked highest for reducing cancer-related fatigue.
Strengthening exercise ranked lowest in this particular analysis.
The authors call for larger, higher-quality trials before adopting one approach as best.

Why this matters on shift

Cancer-related fatigue is one of the most common and distressing symptoms patients report, and it sits squarely within nursing's symptom-management role. This may matter for nurses because it signals that simple, low-risk measures such as massage may help, while reminding the team the evidence is not strong enough to set one fixed protocol.

Bedside takeaway

Worth knowing that massage ranked highest among non-drug options for cancer-related fatigue in this network meta-analysis, though the evidence is too uncertain to call any one therapy best.

Nursing implications

Assess cancer-related fatigue routinely as a symptom rather than treating it as unavoidable, offer low-risk comfort measures such as massage where appropriate and consistent with the care plan, and avoid presenting any one therapy as proven best given the wide uncertainty.

Limitations & cautions

Few trials supported each individual therapy, and much of the evidence base used culturally specific modalities, limiting generalizability. The rankings signal promise, not certainty, and do not establish a single recommended program.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

International Journal of Nursing Studies (PubMed). The effectiveness of different non-pharmacological therapies on cancer-related fatigue in cancer patients:A network meta-analysis.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

New ONS/ASCO guideline standardizes antidotes, compresses, and referral for chemo extravasation

In a network meta-analysis, massage ranked best among non-drug therapies for cancer-related fatigue